rs646094

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):​c.3812-8T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 1,608,604 control chromosomes in the GnomAD database, including 41,222 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3260 hom., cov: 32)
Exomes 𝑓: 0.23 ( 37962 hom. )

Consequence

USH2A
NM_206933.4 splice_region, intron

Scores

2
Splicing: ADA: 0.002956
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.63

Publications

17 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A-AS1 (HGNC:40606): (USH2A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 1-216198592-A-C is Benign according to our data. Variant chr1-216198592-A-C is described in ClinVar as [Benign]. Clinvar id is 48508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.3812-8T>G splice_region_variant, intron_variant Intron 17 of 71 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.3812-8T>G splice_region_variant, intron_variant Intron 17 of 71 1 NM_206933.4 ENSP00000305941.3 O75445-1

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31090
AN:
151976
Hom.:
3257
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.209
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.143
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.236
Gnomad OTH
AF:
0.210
GnomAD2 exomes
AF:
0.213
AC:
52476
AN:
246022
AF XY:
0.217
show subpopulations
Gnomad AFR exome
AF:
0.164
Gnomad AMR exome
AF:
0.189
Gnomad ASJ exome
AF:
0.225
Gnomad EAS exome
AF:
0.206
Gnomad FIN exome
AF:
0.153
Gnomad NFE exome
AF:
0.234
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.226
AC:
329796
AN:
1456510
Hom.:
37962
Cov.:
32
AF XY:
0.228
AC XY:
165060
AN XY:
724752
show subpopulations
African (AFR)
AF:
0.160
AC:
5361
AN:
33432
American (AMR)
AF:
0.190
AC:
8495
AN:
44596
Ashkenazi Jewish (ASJ)
AF:
0.225
AC:
5885
AN:
26102
East Asian (EAS)
AF:
0.191
AC:
7555
AN:
39570
South Asian (SAS)
AF:
0.232
AC:
19996
AN:
86160
European-Finnish (FIN)
AF:
0.160
AC:
8157
AN:
51112
Middle Eastern (MID)
AF:
0.212
AC:
1206
AN:
5700
European-Non Finnish (NFE)
AF:
0.234
AC:
260021
AN:
1109570
Other (OTH)
AF:
0.218
AC:
13120
AN:
60268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
12102
24205
36307
48410
60512
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8828
17656
26484
35312
44140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.204
AC:
31103
AN:
152094
Hom.:
3260
Cov.:
32
AF XY:
0.201
AC XY:
14917
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.164
AC:
6798
AN:
41516
American (AMR)
AF:
0.209
AC:
3187
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
767
AN:
3472
East Asian (EAS)
AF:
0.220
AC:
1137
AN:
5160
South Asian (SAS)
AF:
0.220
AC:
1061
AN:
4820
European-Finnish (FIN)
AF:
0.143
AC:
1508
AN:
10578
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.236
AC:
16013
AN:
67946
Other (OTH)
AF:
0.208
AC:
440
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1277
2555
3832
5110
6387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.223
Hom.:
1542
Bravo
AF:
0.204
Asia WGS
AF:
0.185
AC:
643
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 19, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2A Benign:3
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
5.4
DANN
Benign
0.73
PhyloP100
2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0030
dbscSNV1_RF
Benign
0.16
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs646094; hg19: chr1-216371934; COSMIC: COSV107318880; COSMIC: COSV107318880; API